Enabling all Australians with MND to contribute to a big-data research resource that integrates clinical, lifestyle and biological information.
FEATURED RESEARCH PROJECT
Taking results from animal models, this project will screen blood lipids found to be markers of disease progression. Serum and plasma samples accessed from SALSA-SGC will be used for targeted screening of blood lipids knowing that lipid metabolism plays a crucial role in MND. This research will be conducted at the Florey Institute in Melbourne, Victoria, and results are expected late 2022.
Interested in finding out more about this study? Please contact Sophia Luikinga: email@example.com
van Rheenen, W., van der Spek, R.A.A., Bakker, M.K. et al. Nat Genet 53, 1636–1648 (2021). https://doi.org/10.1038/s41588-021-00973-1
Restuadi, R., Garton, F.C., Benyamin, B. et al. Eur J Hum Genet 30, 532–539 (2022). https://doi.org/10.1038/s41431-021-00885-y
Nabais, M.F., Laws, S.M., Lin, T. et al. Genome Biol 22, 90 (2021). https://doi.org/10.1186/s13059-021-02275-5
Iacoangeli, A., Lin, T., Al Khleifat, A., et al. (2020). Cell reports, 33(4), 108323. https://doi.org/10.1016/j.celrep.2020.108323
Subscribe to our mailing list to keep up to date with the latest SALSA-SGC news.